Follow us on:
Breaking News
April 28, 2026
CP Focus - Parenteral Drug Development & Manufacturing
Breaking News
AugustBio_FocusEnl_042826_650x90

Parenteral and Sterile Fill-Finish Development and Manufacturing Trends

 
Parenteral and Sterile Fill-Finish Development and Manufacturing Trends

Strategies and capabilities to accommodate today’s complex therapies.
Read More >>

Biovectra_FocusEnl_042826_650x90
Features & News

Features

Aseptic Manufacturing Containment Strategy

As demands for aseptic manufacturing increase, partnerships among solutions providers will become key to ensuring safe, versatile and optimized drug containment.

SPONSOR

Water for Injection: Strategic Utility and the Case for Outsourcing

Water for injection (WFI) sits at the heart of injectable drug manufacturing.

Features

Future-Ready Vial Fill-Finish: Flexibility Along the Line

Designing modular, automated vial fill-finish lines that balance high-output demands with small-batch precision in an Annex 1-driven world.

Breaking News

Adragos Completes Acquisition of Sanofi’s Sterile Fill-Finish Site in France

Expands Adragos’ sterile injectables network, adding high-volume pre-filled syringe manufacturing capabilities to its vial and ampoule filling operations.

SPONSOR

Next-Gen Topical & Long-Acting Drug Delivery Trends

Topical, transdermal, and long-acting injectables are moving fast, and expectations for purity, performance, and regulatory readiness are higher than ever.

Breaking News

Sharp Sterile Manufacturing to Invest $28M in Lee, MA Site

The expansion will more than double the facility’s filling capacity.

SPONSOR

Introducing Contract Pharma STREAM: Your New Hub for Pharma & Biopharma Insights

Access expert-led webinars, VideoBites, and eBooks focused on manufacturing, supply-chain, drug development, and more.

Featured Resources

Solution Center SPOTLIGHT

Quotient Sciences

Quotient Sciences is a drug development and manufacturing accelerator providing integrated services across the entire development pathway, from candidate selection through commercial manufacturing. We offer global services for drug substance synthesis and manufacturing, formulation development, clinical trials and clinical & commercial manufacturing.

 

Solution Center SPOTLIGHT

Kindeva

Kindeva Drug Delivery is a global contract development and manufacturing organization focused on drug-device combination products. We develop and manufacture products across a broad range of drug-delivery formats, including pulmonary and nasal, injectable, and transdermal. Our service offerings span early-stage feasibility through commercial scale drug product fill-finish, container closure system manufacturing, and drug-device product assembly. Kindeva serves a global client base from our state-of-the-art manufacturing, research, and development facilities located across the U.S. and U.K.